FDA Investigator

Gajendiran Mahadevan

Latest inspection on record: Bengaluru, India, May 2026 · records back to 2016

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 41 inspections across 37 sites are on record.
  • 12 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-15.

At a glance

Inspections

41

Sites

37

Observations

12

Career since

Jul 2016

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Micro Labs, Limited15 May 2026Human Drugs
Apotex Research Private Limited8 May 2026Human Drugs
Pharma Medica Research, Inc.13 Mar 2026Human Drugs
Altasciences Company Inc. - Laval6 Mar 2026Human Drugs
L. Perrigo Company20 Feb 2026Human DrugsOn file

Sites inspected

Micro Labs, LimitedBengaluru, India1 insp.
Apotex Research Private LimitedBangalore, India1 insp.
Pharma Medica Research, Inc.Mississauga, Canada1 insp.
Altasciences Company Inc. - LavalLaval, Canada1 insp.
L. Perrigo CompanyAllegan, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Arindam Dasgupta5 shared
Mohsen Rajabi Abhari4 shared
Amanda Lewin2 shared
Nicola M Fenty-Stewart2 shared
Li-Hong Yeh1 shared
Lori Gioia1 shared

Full investigator report

Get the verbatim findings behind Gajendiran Mahadevan's 12 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators